Physician profile
Peter S Doss
NPI 1609869098
$500.21
in general payments reported to CMS, 2019-2025
10 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.94 · 2020: $27.23 · 2021: $68.10 · 2022: $29.99 · 2023: $33.02 · 2024: $17.89 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $175.73 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Boston Scientific Corporation | $109.37 | 2021-2025 | Obsidio, Embold Fibered |
| Becton, Dickinson and Company | $47.10 | 2023-2025 | |
| Stryker Corporation | $44.43 | 2025 | Artix Mt |
| Angiodynamics, INC. | $28.87 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $22.65 | 2025 | Powerport M.R.I. Implantable Port |
| Argon Medical Devices, INC. | $20.39 | 2025 | Clot Management |
| Leica Microsystems INC. | $20.10 | 2021 | |
| Trisalus Life Sciences, INC. | $16.70 | 2025 | Trinav Infusion System |
| Janssen Pharmaceuticals, INC | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Doss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.